Author

Coralie M. Backlund

Koch Institute for Integrative Cancer Research At MITORCID 0000-0002-8012-8340Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Andrew J. PickeringiD· 1 shared Apoorv ShankeriD· 1 shared Darrell J. IrvineiD· 1 shared Eduardo Nombera BuenoiD· 1 shared Ezra GordoniD· 1 shared Gil Covarrubias· 1 shared Heikyung SuhiD· 1 shared Ivan Susin PiresiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Andrew J. PickeringORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

'Target-and-release' nanoparticles for effective immunotherapy of metastatic ovarian cancer

Ivan Susin Pires, Gil Covarrubias, Victoria F. Gomerdinger, Coralie M. Backlund, Eduardo Nombera Bueno, Margaret M. Billingsley, Mae L. Pryor, Apoorv Shanker, Ezra Gordon, Shengwei Wu, Andrew J. Pickering, Mariane B. Melo, Heikyung Suh, Darrell J. Irvine, Paula Therese Hammond

This study develops IL-12-loaded nanoparticles that enhance immunotherapy for metastatic ovarian cancer by promoting T cell accumulation and sensitizing tumors to checkpoint inhibitors.

Nature Materials · Oct 31, 2025Peer-reviewedBioengineering